Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Generically Dependent Continuant
type: Class

RDF description of Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases - http://irises.unibs.it/resource/item/81926
rights: termsOfUse
date: 2026-08-24T17:44:47
publisher: Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
type: Document

Article
type: Class

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
language: Inglese
type: Generically Dependent Continuant
type: Thing
type: Article
type: Information Content Entity
related by: 4691390
type: Academic Article
type: Document
type: Entity
most specific type: Academic Article
type: Continuant

Information Content Entity
type: Class

4691390
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases